Does high-sensitive C-reactive protein predict outcome after coronary artery bypass?
Elevated high-sensitive C-reactive protein (>2.5 mg·L(-1)) predicts poor early and midterm outcomes after coronary artery bypass.
cFLIP is an important determinant of susceptibility to death receptor-induced apoptosis in bladder carcinomas and could function as a prognostic marker for death receptor sensitivity in future immune therapy.